Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2023-10-19 / Methods Cell Biol 2024;183:51-113Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-07-31 / Cancers (Basel) 2023 Jul;15(15)The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
/in International Publications, Newcastle Disease Virus /von 2023-07-26 / Life (Basel) 2023 Jul;13(8)Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
/in Brain Tumors in Children, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-07-07 / Neurooncol Adv 2023;5(1):vdad081Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2023-04-10 / Genes (Basel) 2023 Apr;14(4)Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment
/in International Publications, Newcastle Disease Virus /von 2023-04-04 / J Cancer Metastasis Treat 2023;9Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2023-03-15 / Front Cell Infect Microbiol 2023;13:1142172Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
/in International Publications, Newcastle Disease Virus, NSCLC /von 2023-02-01 / J Med Virol 2023 Feb;95(2):e28554
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de